A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS

Clinical trial NCT06249867 · RECRUITING

Trial details

NCT number: NCT06249867
Sponsor: Oliver Blanchard
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2024-11-08
Primary completion: 2027-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.